Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesInjection and Intravenous Infusion Chemotherapy and Other Highly Complex Drug or Highly Complex Biologic Agent AdministrationCPT cpt-96405-intralesional-chemotherapy-one-to-seven-lesions
    Ask Trek AI about this page

    CPT 96405: Intralesional Chemotherapy, 1–7 Lesions

    Medicare pays $88 on average nationally for this procedure.

    CPT code 96405 describes intralesional chemotherapy in which a clinician injects chemotherapeutic agent(s) directly into a lesion or tumor, treating one to seven lesions; service type: intralesional chemotherapy procedure; typical site of service: outpatient clinic, physician office, or ambulatory surgical center where lesion-directed injections are performed.

    For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.

    Customize your policy alerts

    Sign up for cpt 96405 policy alerts

    Get alerted when payer policies referencing 96405 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A typical patient is a 62-year-old with metastatic cutaneous squamous cell carcinoma presenting with one to seven palpable or visible cutaneous and subcutaneous tumor nodules. The patient is seen in an outpatient infusion clinic or procedure room. After informed consent, lesion mapping and local anesthesia are performed. The provider injects a cytotoxic agent or chemotherapeutic agent directly into each targeted lesion (one to seven lesions) using sterile technique. Vital signs and comfort are monitored during and after injection. Post-procedure instructions include local wound care, signs of infection or systemic toxicity, and a follow-up visit to assess lesion response and need for additional local or systemic therapy. Typical sites of service are ambulatory infusion centers, hospital outpatient departments, or office-based procedure suites.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    96405Injections of antineoplastic agents into a lesion or tumor; 1 to 7 lesionsPrimary procedure: intralesional administration of chemotherapy directly into one to seven lesions.
    96401Chemotherapy administration, subcutaneous or intramuscular; non-hormonal antineoplastic agentMay be used for systemic or regional chemotherapy administration when intralesional injection is not performed.
    96409Chemotherapy administration, intra-arterial; single or initial drugPerformed when regional intra-arterial chemotherapy is indicated as part of multimodality treatment.
    11900Injection, intralesional; up to and including 7 lesionsWhen non-antineoplastic agents (e.g., sclerosing or other therapeutic agents) are injected into lesions; differentiates non-chemotherapy intralesional injections.
    99024Postoperative follow-up visit, included in global period (used for reporting separate visit)Used to report postoperative or follow-up visits if payer allows separate reporting outside the global period.

    Related Modifiers

    10 rows

    ModifierDescriptionWhen to Use
    25CPT modifier 25 indicates that on the same day as another procedure or service, the same physician or other qualified health care professional provided a significant, separately identifiable…- When to apply: Use modifier 25 only on an E/M code to indicate the same provider delivered a significant, separately identifiable E/M service on the same day as another procedure or service — i.e.,…
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    51Modifier –51 (Multiple Procedures) is used when the same provider performs multiple procedures in the same session to identify secondary, non‑exempt procedures and indicate payment reduction logic…- Use modifier -51 when the same provider performs multiple distinct procedures during the same patient encounter: report the highest‑valued procedure first (no modifier) and append -51 to…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…
    79Modifier 79 indicates a surgical procedure performed during the postoperative global period of a prior surgery that is unrelated to the original procedure. Per AMA/CPT and CMS guidance, it is…- Use modifier 79 when the same physician (or same‑specialty physician in the same group) performs a surgical procedure during the postoperative global period of a prior surgery and the new procedure…
    80CPT® Modifier 80 (Assistant Surgeon) is appended to a surgical CPT code when a physician (MD or DO) provides full, continuous assistance throughout the operative procedure. It is intended only for…- Use CPT Modifier -80 when a physician (MD or DO) serves as an assistant surgeon and provides full, continuous assistance throughout the entire operative procedure; append -80 to the surgical CPT…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    2251E1300X
    252Y00000X
    193400000X
    103TP2701X
    315D00000X
    2279E1000X
    207RC0000X
    253Z00000X

    Related ICD-10-CM Codes

    22 rows

    ICD-10-CM CodeDescription
    C15.9Malignant neoplasm of esophagus, unspecified
    C16.9Malignant neoplasm of stomach, unspecified
    C18.9Malignant neoplasm of colon, unspecified
    C25.9Malignant neoplasm of pancreas, unspecified
    C34.90Malignant neoplasm of unspecified part of unspecified bronchus or lung
    C43.9Malignant melanoma of skin, unspecified
    C44.212Basal cell carcinoma of skin of right ear and external auricular canal
    C44.219Basal cell carcinoma of skin of left ear and external auricular canal
    C44.612Basal cell carcinoma of skin of right upper limb, including shoulder
    C44.722Squamous cell carcinoma of skin of right lower limb, including hip

    Showing 1–10 of 22

    Related Payer Policy Updates

    Specialty: Hematology/Oncology1 / 3

    10 rows

    PolicyPayerEffective Date
    Bendamustine Products Coverage Criteriablue cross blue shield - tennessee2027-01-30
    T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and RomidepsinMass General Brigham Health Plan2027-01-04
    Brentuximab Vedotin (Adcetris®) Coverage Criteriablue cross blue shield - tennessee2026-12-31
    Pemetrexed Coverageblue cross blue shield - tennessee2026-12-31
    Tumor Treatment Fields - Medical PolicyHealth-New-England2026-12-01
    Extracorporeal PhotopheresisCigna2026-11-15
    Hematology - AphexdaCigna2026-11-15
    VonvendiCigna2026-11-15
    Extracorporeal PhotopheresisCigna2026-11-15
    Yartemlea (narsoplimab-wuug) Coverage for TA-TMANeighborhood Health Plan of Rhode Island2026-11-01

    Related Codes

    CPT-96401-SUBCUTANEOUS-INTRAMUSCULAR-CHEMOTHERAPY-ADMINISTRATION

    CPT 96401: Subcutaneous or Intramuscular Nonhormonal Chemotherapy

    CPT-96402-SUBCUTANEOUS-INTRAMUSCULAR-HORMONAL-ANTINEOPLASTIC-ADMINISTRATION

    CPT 96402: Subcutaneous/Intramuscular Hormonal Anti‑Neoplastic Administration

    CPT-96406-INTRALESIONAL-CHEMOTHERAPY-MORE-THAN-7-LESIONS

    CPT 96406: Intralesional Chemotherapy for >7 Lesions

    CPT-96409-INTRAVENOUS-PUSH-CHEMOTHERAPY-INITIAL-DRUG

    CPT 96409: Intravenous Push Chemotherapy, Single/Initial Drug

    CPT-96411-ADD-ON-INTRAVENOUS-PUSH-CHEMOTHERAPY-DRUG

    CPT 96411: Add-On IV Push for Additional Chemotherapy Drug

    CPT-96413-INTRAVENOUS-CHEMOTHERAPY-INFUSION-INITIAL-HOUR

    CPT 96413: Intravenous Chemotherapy Infusion, Initial Hour

    CPT-96415-ADDITIONAL-HOUR-CHEMOTHERAPY-INTRAVENOUS-INFUSION

    CPT 96415: Continued Intravenous Chemotherapy Infusion, Per Additional Hour

    CPT-96416-CHEMOTHERAPY-INITIATION-PORTABLE-IMPLANTABLE-PUMP

    CPT 96416: Initiation of Intravenous Chemotherapy via Pump

    CPT-96417-ADD-ON-IV-CHEMOTHERAPY-INFUSION-DIFFERENT-AGENT

    CPT 96417: Continued Intravenous Chemotherapy Administration

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.